Open-label PK Study of Iron Isomaltoside 1000 (Monofer) Administered by 500 mg IV Injection or 1000 mg IV Infusion to Patients With Inflammatory Bowel Disease

NCT01213680 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Inflammatory Bowel Disease

Interventions

DRUG: Monofer (iron isomaltoside 1000)
DRUG: Monofer

Sponsor

Pharmacosmos A/S